Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
When ASOA members and attendees of the ASOA Annual Meeting provide feedback, the leading U.S. society for ophthalmic practice administrators listens. There are many areas at the 2025 ASOA Annual Meeting that have been significantly influenced by attendee and member feedback.
Avi Wallerstein, MD, FRCSC, and Mathieu Gauvin, PhD, discussed mEYEstro, a new software they created to automate and standardize the reporting of refractive surgery outcomes. They shared why this is an area of need and the features of mEYEstro.
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
MIGS has continued to expand in its application for a wide variety of patients with varying degrees of glaucoma. Several physicians discussed where various MIGS procedures fit into interventional glaucoma, including applications for standalone MIGS and how it continues to play a role in conjunction with cataract surgery.
Two glaucoma specialists spoke with EyeWorld about the current role of SLT, as well as products in development and further research in the glaucoma laser space.
While glaucoma treatment is shifting toward a more interventional approach, two physicians said the use of drop therapy is alive and well. It is trending toward being an adjunctive therapy as more ophthalmologists are beginning to figure out what pharmaceutical and procedural combinations best suit their patients.
Many MIGS procedures are proving useful and accessible not just to the glaucoma specialist but to comprehensive ophthalmologists as well. Two ophthalmologists discussed who should be performing glaucoma surgery, as well as ways to learn and stay fresh with some of these techniques.
While ophthalmologists agree that glaucoma drops are not likely to go extinct as part of glaucoma management, recent innovation continues to shift their place in many physicians’ glaucoma treatment algorithm. One of these disruptive innovations is sustained drug delivery. Two experts weighed in on the topic.
ASCRS Annual Meeting Program Chair Thomas Samuelson, MD, spoke to EyeWorld about the upcoming Annual Meeting and what he’s looking forward to in Los Angeles, California.